✦ LIBER ✦

Nutritional support for patients suffering from intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

✍ Scribed by Osamu Imataki; Shigetoshi Nakatani; Terumi Hasegawa; Miki Kondo; Kiyoko Ichihashi; Mitsuko Araki; Toshihiko Ishida; Sung-Won Kim; Shin-ichiro Mori; Takahiro Fukuda; Kensei Tobinai; Ryuji Tanosaki; Atsushi Makimoto; Yoichi Takaue

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 216 KB
Volume: 81
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20700

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Squamous cell carcinoma of the tongue co

Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

✍ Ching H. Szeto; Tony W.H. Shek; Albert K.W. Lie; Wing Y. Au; Anthony P.W. Yuen; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 2 views

Recombinant human soluble tumor necrosis

Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

✍ Alessandro Busca; Franco Locatelli; Filippo Marmont; Cristina Ceretto; Michele F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

## Abstract Etanercept is a recombinant human soluble tumor necrosis factor (TNF‐α) receptor fusion protein that inhibits TNF‐α, a major mediator in the pathogenesis of graft‐versus‐host disease (GVHD). The purpose of our study was to evaluate the safety and efficacy of etanercept therapy in 21 pat